Literature DB >> 26509828

Molecular screening of the Cw antigen for typing donors compatible with patients with anti-MAR-like antibodies.

Agnieszka Orzińska1, Katarzyna Guz1, Bogumiła Michalewska1, Ewa Brojer1.   

Abstract

Entities:  

Year:  2015        PMID： 26509828      PMCID： PMC5111387          DOI： 10.2450/2015.0044-15

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  3 in total

1.  Molecular basis of the RhCW (Rh8) and RhCX (Rh9) blood group specificities.

Authors:  I Mouro; Y Colin; P Sistonen; P Y Le Pennec; J P Cartron; C Le Van Kim
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

2.  MAR, a novel high-incidence Rh antigen revealing the existence of an allelic sub-system including Cw (Rh8) and Cx (Rh9) with exceptional distribution in the Finnish population.

Authors:  P Sistonen; H Sareneva; A Pirkola; J Eklund
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

3.  A MAR-like antibody in a DCWe/DCWe person.

Authors:  K P O'Shea; R Oyen; L Sausais; V A Stephens; G F Stillwell; L A Bisgard; J Martin; M E Reid
Journal:  Transfusion       Date:  2001-01       Impact factor: 3.157
  3 in total
  2 in total

1.  Molecular study of Cw /Cx antigens and frequency of Rh phenotypes in southeast Brazilian blood donors.

Authors:  Sidneia S Costa; Thamy C Souza Silva; Akemi Kuroda Chiba; Bruno R Cruz; Dante Mário Langhi Junior; José O Bordin
Journal:  J Clin Lab Anal       Date:  2018-06-21       Impact factor: 2.352

2.  A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors.

Authors:  Agnieszka Orzińska; Katarzyna Guz; Michał Mikula; Maria Kulecka; Anna Kluska; Aneta Balabas; Monika Pelc-Kłopotowska; Jerzy Ostrowski; Ewa Brojer
Journal:  Blood Transfus       Date:  2017-03-10       Impact factor: 3.443
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.